AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Cadmium nanoclusters in a protein matrix: Synthesis, characterization, and application in targeted drug delivery and cellular imaging

Morteza Sarparast1,§, Abolhassan Noori1,§, Hoda Ilkhani1, S. Zahra Bathaie2, Maher F. El-Kady3,4, Lisa J. Wang3, Huong Pham3, Kristofer L. Marsh3, Richard B. Kaner3,5( ), Mir F. Mousavi1,3( )
Department of Chemistry Tarbiat Modares UniversityTehran 14115-175Iran
Department of Clinical Biochemistry Faculty of Medical Sciences, Tarbiat Modares UniversityTehran 14115-111Iran
Department of Chemistry and BiochemistryUniversity of CaliforniaLos AngelesLos AngelesCA90095USA
Department of ChemistryFaculty of ScienceCairo UniversityGiza12613Egypt
California NanoSystems InstituteUniversity of CaliforniaLos AngelesLos AngelesCA90095USA

§ These authors contributed equally to this work.

Show Author Information
An erratum to this article is available online at:

Abstract

Biotemplated metal nanoclusters have garnered much attention owing to their wide range of potential applications in biosensing, bioimaging, catalysis, and nanomedicine. Here, we report the synthesis of stable, biocompatible, water-soluble, and highly fluorescent bovine serum albumin-templated cadmium nanoclusters (CdNCs) through a facile one-pot green method. We covalently conjugated hyaluronic acid (HA) to the CdNCs to form a pH-responsive, tumortargeting theranostic nanocarrier with a sustained release profile for doxorubicin (DOX), a model anticancer drug. The nanocarrier showed a DOX encapsulation efficiency of about 75.6%. DOX release profiles revealed that 74% of DOX was released at pH 5.3, while less than 26% of DOX was released at pH 7.4 within the same 24-h period. The nanocarrier selectively recognized MCF-7 breast cancer cells expressing CD44, a cell surface receptor for HA, whereas no such recognition was observed with HA receptor-negative HEK293 cells. Biocompatibility of the nanocarrier was evaluated through cytotoxicity assays with HEK293 and MCF-7 cells. The nanocarrier exhibited very low to no cytotoxicity, whereas the DOX-loaded nanocarrier showed considerable cellular uptake and enhanced MCF-7 breast cancer cell-killing ability. We also confirmed the feasibility of using the highly fluorescent nanoconjugate for bioimaging of MCF-7 and HeLa cells. The superior targeted drug delivery efficacy, cellular imaging capability, and low cytotoxicity position this nanoconjugate as an exciting new nanoplatform with promising biomedical applications.

Graphical Abstract

Electronic Supplementary Material

Download File(s)
12274_2016_1201_MOESM1_ESM.pdf (2.1 MB)

References

【1】
【1】
 
 
Nano Research
Pages 3229-3246

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Sarparast M, Noori A, Ilkhani H, et al. Cadmium nanoclusters in a protein matrix: Synthesis, characterization, and application in targeted drug delivery and cellular imaging. Nano Research, 2016, 9(11): 3229-3246. https://doi.org/10.1007/s12274-016-1201-z

1434

Views

48

Crossref

N/A

Web of Science

50

Scopus

4

CSCD

Received: 24 April 2016
Revised: 02 July 2016
Accepted: 04 July 2016
Published: 05 August 2016
© Tsinghua University Press and Springer-Verlag Berlin Heidelberg 2016